BMS drug Baraclude was first approved in March 2005 and subsequent approvals in Japan and the five major EU markets (France, Germany, Italy, Spain, and th....
15.00
2
Apr, 2020
Vemlidy Drug Sales & Forecast
GileadSciences drug Vemlidy is an oral formulation of TAF dosed once a day for the treatment of chronic hepatitis B virus (HBV) infection in adults with c....
15.00
Confirm All Clear!
Do You Realy want to delete all items from you CART?